, Volume 8, Issue 1, pp 60–66 | Cite as

Development of Novel Doxorubicin Loaded Biodegradable Polymeric Nanofibers as the Anticancer Drug Delivery Systems

  • Mohsen Bakhtiari
  • Roya Salehi
  • Abolfazl Akbarzadeh
  • Soodabeh Davaran


Through the present research, for the first time, doxorubicin hydrochloride (DOX)-loaded poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone) (PCL-PEG-PCL, PCEC) nanofibers were obtained by blending electrospinning method. The physicochemical characteristics of the DOX/PCEC nanofibers were fully evaluated. Nanofibers had homogeneous morphology with mean diameters ranging from 80 to 300 nm. The drug releasing behavior showed the faster release rate by increasing the drug content in nanofibers. The in vitro release profile and release kinetics from the DOX/PCEC nanofibers confirmed that the release profile followed Korsmeyer–Peppas model suggesting a Fickian diffusion as a major drug release mechanism.


Nanofibers Doxorubicin Electrospinning Biodegradable polymers Korsmeyer–Peppas model Fluorescence 



This work was financially supported by the “Department of Medical Nanotechnology, Faculty of Advanced Medical Science of Tabriz University” of Tabriz University of Medical Sciences. The authors thank the Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, for all support provided.

Compliance with Ethical Standards

Declaration of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Zeighamian, V., et al. (2015). PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells. Artificial Cells, Nanomedicine, and Biotechnology, 44, 1–8.Google Scholar
  2. 2.
    Salehi, R., et al. (2013). Stimuli-responsive nanofibers prepared from poly (N-isopropylacrylamide-acrylamide-vinylpyrrolidone) by electrospinning as an anticancer drug delivery. Designed Monomers and Polymers, 16(6), 515–527.CrossRefGoogle Scholar
  3. 3.
    Xu, X., et al. (2008). The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning. European Journal of Pharmaceutics and Biopharmaceutics, 70(1), 165–170.CrossRefGoogle Scholar
  4. 4.
    Zamani, M., Prabhakaran, M. P., & Ramakrishna, S. (2013). Advances in drug delivery via electrospun and electrosprayed nanomaterials. International Journal of Nanomedicine, 8, 2997.Google Scholar
  5. 5.
    Eatemadi, A., et al. (2015). Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Artificial Cells, Nanomedicine, and Biotechnology, 44, 1–10.Google Scholar
  6. 6.
    Feng, R., Song, Z., & Zhai, G. (2012). Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. International Journal of Nanomedicine, 7, 4089.CrossRefGoogle Scholar
  7. 7.
    Sridhar, R., et al. (2015). Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals. Chemical Society Reviews, 44(3), 790–814.CrossRefGoogle Scholar
  8. 8.
    Ardeshirzadeh, B., et al. (2015). Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds. Materials Science and Engineering: C, 48, 384–390.CrossRefGoogle Scholar
  9. 9.
    Sampath, M., et al. (2014). Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloids and Surfaces B: Biointerfaces, 117, 128–134.CrossRefGoogle Scholar
  10. 10.
    Valizadeh, A., et al. (2014) Preparation and characterization of novel electrospun poly (ϵ-caprolactone)-based nanofibrous scaffolds. Artificial Cells, Nanomedicine, and Biotechnology, 44, 1–6.Google Scholar
  11. 11.
    Agarwal, S., Greiner, A., & Wendorff, J. H. (2013). Functional materials by electrospinning of polymers. Progress in Polymer Science, 38(6), 963–991.CrossRefGoogle Scholar
  12. 12.
    Hu, X., et al. (2014). Electrospinning of polymeric nanofibers for drug delivery applications. Journal of Controlled Release, 185, 12–21.CrossRefGoogle Scholar
  13. 13.
    Qiu, K., et al. (2013). Doxorubicin-loaded electrospun poly (L-lactic acid)/mesoporous silica nanoparticles composite nanofibers for potential postsurgical cancer treatment. Journal of Materials Chemistry B, 1(36), 4601–4611.CrossRefGoogle Scholar
  14. 14.
    Wu, S., et al. (2013). Adsorption properties of doxorubicin hydrochloride onto graphene oxide: equilibrium, kinetic and thermodynamic studies. Materials, 6(5), 2026–2042.CrossRefGoogle Scholar
  15. 15.
    Mamaghani, P. Y., et al. (2015). Synthesis, characterization, and viscoelastic behavior of thermothickening poly (N-Isopropylacrylamide-Methacrylicacide-Vinylpyrrolidone) nanogels as an injectable biocompatible drug carrier. International Journal of Polymeric Materials and Polymeric Biomaterials, 64(2), 55–63.CrossRefGoogle Scholar
  16. 16.
    Ta, H. T., et al. (2009). A chitosan–dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma. Biomaterials, 30(21), 3605–3613.CrossRefGoogle Scholar
  17. 17.
    Salehi, R., Rasouli, S., & Hamishehkar, H. (2015). Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate. International Journal of Pharmaceutics, 487(1), 274–284.CrossRefGoogle Scholar
  18. 18.
    Akbarzadeh, A., et al. (2012). Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnology, Science and Applications, 5, 13.Google Scholar
  19. 19.
    Yang, S. R., Lee, H. J., & Kim, J.-D. (2006). Histidine-conjugated poly (amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin. Journal of Controlled Release, 114(1), 60–68.CrossRefGoogle Scholar
  20. 20.
    Zarouni, M., et al. (2015). Biocompatible polymer coated paramagnetic nanoparticles for doxorubicin delivery: synthesis and anticancer effects against human breast cancer cells. International Journal of Polymeric Materials and Polymeric Biomaterials, 64(14), 718–726.CrossRefGoogle Scholar
  21. 21.
    Gabizon, A., & Martin, F. (1997). Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Drugs, 54(4), 15–21.CrossRefGoogle Scholar
  22. 22.
    Salehi, R., et al. (2014). Interaction, controlled release, and antitumor activity of doxorubicin hydrochloride from pH-sensitive P (NIPAAm-MAA-VP) nanofibrous scaffolds prepared by green electrospinning. International Journal of Polymeric Materials and Polymeric Biomaterials, 63(12), 609–619.CrossRefGoogle Scholar
  23. 23.
    Liu, S., et al. (2013). Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. Journal of Materials Chemistry B, 1(1), 101–109.CrossRefGoogle Scholar
  24. 24.
    Xu, B., et al. (2010). Amphiphilic biodegradable poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone) triblock copolymers: synthesis, characterization and their use as drug carriers for folic acid. Polymer Bulletin, 64(6), 537–551.CrossRefGoogle Scholar
  25. 25.
    Wei, X., et al. (2009). Biodegradable poly (ɛ-caprolactone)–poly (ethylene glycol) copolymers as drug delivery system. International Journal of Pharmaceutics, 381(1), 1–18.CrossRefGoogle Scholar
  26. 26.
    Zhang, D., et al. (2012). Osteogenic differentiation of human placenta-derived mesenchymal stem cells (PMSCs) on electrospun nanofiber meshes. Cytotechnology, 64(6), 701–710.CrossRefGoogle Scholar
  27. 27.
    Shen, X., et al. (2011). Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery. International Journal of Pharmaceutics, 408(1), 200–207.CrossRefGoogle Scholar
  28. 28.
    Meinel, A. J., et al. (2012). Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics, 81(1), 1–13.CrossRefGoogle Scholar
  29. 29.
    Piras, A., et al. (2006). Development of diclofenac sodium releasing bio-erodible polymeric nanomats. Journal of Nanoscience and Nanotechnology, 6(9–10), 3310–3320.CrossRefGoogle Scholar
  30. 30.
    Ngawhirunpat, T., et al. (2009). Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent. Pharmaceutical Development and Technology, 14(1), 73–82.CrossRefGoogle Scholar
  31. 31.
    Sun, X.-Z., et al. (2013). Electrospun curcumin-loaded fibers with potential biomedical applications. Carbohydrate Polymers, 94(1), 147–153.CrossRefGoogle Scholar
  32. 32.
    Ma, G., et al. (2011). Paclitaxel loaded electrospun porous nanofibers as mat potential application for chemotherapy against prostate cancer. Carbohydrate Polymers, 86(2), 505–512.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Student Research CommitteeTabriz University of Medical SciencesTabrizIran
  2. 2.Department of Medical Nanotechnology, School of Advanced Medical SciencesTabriz University of Medical SciencesTabrizIran
  3. 3.Stem Cell Research CenterTabriz University of Medical SciencesTabrizIran
  4. 4.Biotechnology Research CenterTabriz University of Medical SciencesTabrizIran
  5. 5.Universal Scientific Education and Research Network (USERN)TabrizIran
  6. 6.Joint Ukraine-Azerbaijan International Research and Education Center of Nanobiotechnology and Functional NanosystemsDrohobychUkraine

Personalised recommendations